Literature DB >> 4589858

Antiserum inactivation of electrophoretically purified M13 diploid virions: model for the F-specific filamentous bacteriophages.

J Beaudoin, D Pratt.   

Abstract

Antiserum inactivation experiments were carried out on electrophoretically purified diploid virions from a cross between two complementing amber mutants of phage M13. The total (homozygous plus heterozygous) diploid population, assayed on a permissive host where only one genome is needed for plaque formation, was inactivated at the same rate as haploids. Heterozygous diploids, assayed on a nonpermissive host, where both genomes are needed for plaque formation, were twice as sensitive as haploids and the total diploid population. These results have led us to propose a model for serum inactivation of the F-specific filamentous phages. According to this model, phage-neutralizing antibodies attach anywhere along the length of the phage and allow the phage to penetrate only up to the first bound antibody molecule.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4589858      PMCID: PMC355317     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  SOME PHYSICAL-CHEMICAL AND BIOLOGICAL PROPERTIES OF THE ROD-SHAPED COLIPHAGE M13.

Authors:  W O SALIVAR; H TZAGOLOFF; D PRATT
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

2.  Purification of single- and double-length M13 virions by polyacrylamide gel electrophoresis.

Authors:  J Beaudoin; T J Henry; D Pratt
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

3.  Studies on the bacteriophage fl. I. Alkali-induced disassembly of the phage into DNA and protein.

Authors:  E F Rossomando; N D Zinder
Journal:  J Mol Biol       Date:  1968-09-28       Impact factor: 5.469

4.  Physical changes associated with heating bacteriophage f1.

Authors:  E F Rossomando; H A Bladen
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

5.  The attachment of the male-specific bacteriophage F1 to sensitive strains of Escherichia coli.

Authors:  L G Caro; M Schnös
Journal:  Proc Natl Acad Sci U S A       Date:  1966-07       Impact factor: 11.205

6.  Purification and properties of diploid particles of coliphage M13.

Authors:  W O Salivar; T J Henry; D Pratt
Journal:  Virology       Date:  1967-05       Impact factor: 3.616

7.  Conditional lethal mutants of the small filamentous coliphage M13. II. Two genes for coat proteins.

Authors:  D Pratt; H Tzagoloff; J Beaudoin
Journal:  Virology       Date:  1969-09       Impact factor: 3.616

8.  Active fragments of a filamentous bacteriophage.

Authors:  G Fareed; K A Ippen; R C Valentine
Journal:  Biochem Biophys Res Commun       Date:  1966-11-11       Impact factor: 3.575

9.  Conditional lethal mutants of the small filamentous coliphage M13. I. Isolation, complementation, cell killing, time of cistron action.

Authors:  D Pratt; H Tzagoloff; W S Erdahl
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

10.  The proteins of bacteriophage M13.

Authors:  T J Henry; D Pratt
Journal:  Proc Natl Acad Sci U S A       Date:  1969-03       Impact factor: 11.205

View more
  4 in total

1.  Purification of single- and double-length M13 virions by polyacrylamide gel electrophoresis.

Authors:  J Beaudoin; T J Henry; D Pratt
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

2.  Improvements in the production of purified M13 bacteriophage bio-nanoparticle.

Authors:  Paolo Passaretti; Inam Khan; Timothy R Dafforn; Pola Goldberg Oppenheimer
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

3.  Genetic analysis of the filamentous bacteriophage packaging signal and of the proteins that interact with it.

Authors:  M Russel; P Model
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

Review 4.  Phages and their potential to modulate the microbiome and immunity.

Authors:  Sara Federici; Samuel P Nobs; Eran Elinav
Journal:  Cell Mol Immunol       Date:  2020-09-08       Impact factor: 11.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.